Eun Bong Lee
Seoul National University of Science and Technology(KR)Seoul National University(KR)New Generation University College(ET)Seoul National University Hospital(KR)Seoul National University Bundang Hospital(KR)National University College(PR)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Autoimmune and Inflammatory Disorders Research, Systemic Sclerosis and Related Diseases, Ocular Diseases and Behçet’s Syndrome
Most-Cited Works
- → Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis(2012)931 cited
- → Tofacitinib versus Methotrexate in Rheumatoid Arthritis(2014)765 cited
- → Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci(2010)522 cited
- → Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials(2017)388 cited
- → Phase IIb dose‐ranging study of the oral JAK inhibitor tofacitinib (CP‐690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease‐modifying antirheumatic drugs(2011)376 cited
- → Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial